Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000519197 | SCV000619983 | uncertain significance | not provided | 2022-03-23 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Labcorp Genetics |
RCV000556075 | SCV000640886 | benign | Nemaline myopathy 2 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000519197 | SCV003810205 | uncertain significance | not provided | 2023-02-09 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000519197 | SCV005187949 | uncertain significance | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV000556075 | SCV001454971 | uncertain significance | Nemaline myopathy 2 | 2019-11-11 | no assertion criteria provided | clinical testing |